Oppenheimer & CO Inc Pliant Therapeutics, Inc. Transaction History

Oppenheimer & CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.85 - $19.15 $16,165 - $24,090	-1,258 Reduced 10.37%	10,877 $196,000
Q3 2023 Nov 07, 2023	BUY	$14.58 - $20.15 $176,928 - $244,520	12,135 New	12,135 $210,000
Q1 2023 May 10, 2023	BUY	$18.73 - $36.26 $143,602 - $278,005	7,667 New	7,667 $203,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.